Yabao Pharmaceutical Group Co., Ltd (600351.SS) Key Statistics
$6.64SHH: 600351.SSMarket Cap $4.85B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Yabao Pharmaceutical Group Co., Ltd (600351.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
14.91
P/B ratioShare price divided by book value per share.
1.72
P/S ratioMarket value divided by annual revenue.
2.16
PEG ratioP/E divided by the earnings growth rate.
2.16
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
7.92
EV / RevenueEnterprise value against annual revenue.
1.64
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
6.70%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
52.46%
Operating marginRevenue left after operating costs.
16.86%
Net marginRevenue left after every cost, including tax and interest.
14.39%
Return on equityProfit as a percentage of shareholders’ equity.
10.92%
Return on assetsProfit as a percentage of total assets.
6.29%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.81
Quick ratioThe same, excluding inventory.
3.04
Debt to equityTotal borrowings against shareholders’ equity.
0.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.47
Book value per shareShareholders’ equity divided by shares outstanding.
$4.08
Shares outstandingShares currently issued.
692,000,046
Market capitalisationShare price times shares outstanding.
$4.85B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
3,415
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
8.22%
Payout ratioShare of profit paid out as dividends.
What is Yabao Pharmaceutical Group Co., Ltd's P/E ratio?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) trades on a price-to-earnings ratio of 14.91.
What is Yabao Pharmaceutical Group Co., Ltd's return on equity?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) reports a return on equity of 10.92%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Yabao Pharmaceutical Group Co., Ltd carry?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) has a debt-to-equity ratio of 0.01, which compares total borrowings with shareholders' equity.
What is Yabao Pharmaceutical Group Co., Ltd's profit margin?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) keeps 14.39% of revenue as net profit after every cost, including tax and interest.